The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT-EHA CAR-T 2019 | Treating patients on the NHS with CAR T-cell therapy
Claire Roddie
• 8 Mar 2019
Claire Roddie, MD, PhD University College London Hospitals NHS Foundation Trust, London, UK, speaks about treating patients on the NHS with CAR T-cell therapy at the 1st European CAR T-Cell Meeting, held in Paris, France, co-organized by the European Society for Blood & Marrow Transplantation (EBMT) and the European Hematology Association (EHA).
